Loading...

Ono Pharmaceutical Co., Ltd.

OPHLY•PNK
Healthcare
Drug Manufacturers - General
$4.78
$-0.06(-1.24%)
U.S. Market opens in 7h 53m

Ono Pharmaceutical Co., Ltd. (OPHLY) Stock Overview

Explore Ono Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.7B
P/E Ratio16.91
EPS (TTM)$0.23
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$6.06
3 Months$6.30
1 Year Target$5.61

OPHLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ono Pharmaceutical Co., Ltd. (OPHLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.61.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.91 and a market capitalization of 6.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.34%
5-Day Change
-0.31%
1-Month Change
-7.64%
3-Month Change
-4.88%
6-Month Change
19.38%
Year-to-Date (YTD) Change
4.95%
1-Year Change
23.39%
3-Year Change
-29.36%
5-Year Change
-44.48%
All-Time (Max) Change
28.33%

Contact Information

https://www.ono-pharma.com
81 6 6263 5670
8-2, Kyutaromachi 1-chome, Osaka, NaN, 541-8564

Company Facts

3,853 Employees
IPO DateOct 2, 2012
CountryJP
Actively Trading

Frequently Asked Questions